We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$98.8B
AUM Growth
-$3.4B
Cap. Flow
+$2.69B
Cap. Flow %
2.72%
Top 10 Hldgs %
24.29%
Holding
4,219
New
200
Increased
1,781
Reduced
1,776
Closed
283
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FVD icon
76
First Trust Value Line Dividend Fund
FVD
$8.4B
$241M 0.24%
6,736,973
+568,183
+9% +$22.5M
VIG icon
77
Vanguard Dividend Appreciation ETF
VIG
$114B
$240M 0.24%
1,778,050
+27,788
+2% +$4.14M
TGT icon
78
Target
TGT
$68B
$235M 0.24%
1,586,643
+148,094
+10% +$23.7M
XLC icon
79
State Street Communication Services Select Sector SPDR ETF
XLC
$22.5B
$229M 0.23%
4,779,550
-1,189,160
-20% -$65.4M
XLY icon
80
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.8B
$227M 0.23%
3,186,424
-206,442
-6% -$16.2M
ACN icon
81
Accenture
ACN
$108B
$226M 0.23%
877,032
+23,002
+3% +$6.65M
TXN icon
82
Texas Instruments
TXN
$261B
$225M 0.23%
1,455,294
+14,573
+1% +$2.44M
SPGI icon
83
S&P Global
SPGI
$120B
$224M 0.23%
734,318
+70
+0% +$25K
VPL icon
84
Vanguard FTSE Pacific ETF
VPL
$8.44B
$223M 0.23%
3,879,673
+117,996
+3% +$7.54M
BMY icon
85
Bristol-Myers Squibb
BMY
$132B
$217M 0.22%
3,046,338
-213,971
-7% -$15.5M
ORCL icon
86
Oracle
ORCL
$423B
$216M 0.22%
3,533,886
+683,663
+24% +$50.1M
FTCS icon
87
First Trust Capital Strength ETF
FTCS
$7.95B
$216M 0.22%
3,244,572
+105,108
+3% +$7.55M
CCI icon
88
Crown Castle
CCI
$32.2B
$212M 0.21%
1,469,740
+47,859
+3% +$8.19M
LLY icon
89
Eli Lilly
LLY
$1.06T
$212M 0.21%
654,962
-21,271
-3% -$6.74M
ALL icon
90
Allstate
ALL
$67.5B
$210M 0.21%
1,682,774
+118,592
+8% +$14.7M
AMGN icon
91
Amgen
AMGN
$222B
$207M 0.21%
920,169
+98,386
+12% +$23.8M
XLP icon
92
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.7B
$206M 0.21%
3,091,635
+2,299,337
+290% +$168M
HON icon
93
Honeywell
HON
$78B
$206M 0.21%
1,308,758
+11,389
+0.9% +$1.98M
WMB icon
94
Williams Companies
WMB
$86.1B
$204M 0.21%
7,142,614
+27,599
+0.4% +$899K
DIS icon
95
Walt Disney
DIS
$181B
$204M 0.21%
2,166,541
-142,549
-6% -$15.3M
SHY icon
96
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$204M 0.21%
2,510,580
+764,490
+44% +$62.9M
TMO icon
97
Thermo Fisher Scientific
TMO
$220B
$203M 0.21%
400,588
+8,070
+2% +$4.52M
TFC icon
98
Truist Financial
TFC
$64B
$195M 0.2%
4,485,941
-27,978
-0.6% -$1.35M
LHX icon
99
L3Harris
LHX
$53.4B
$195M 0.2%
938,579
+427,649
+84% +$98.6M
DE icon
100
Deere & Co
DE
$168B
$192M 0.19%
574,935
+32,277
+6% +$11.1M

Similar funds

Raymond James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Raymond James & Associates held 4,219 positions worth $98.8B, down 3.3% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2022 filing shows 200 new, 1,781 increased, 1,776 reduced and 283 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M. The largest sale was iShares Core 1-5 Year USD Bond ETF, an estimated $255M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2022 buy was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2022, an estimated $620M increase.
  • Raymond James & Associates's biggest Q3 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $255M.
  • Raymond James & Associates fully exited CDK Global, Inc. in Q3 2022, selling an estimated $36M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $98.8B portfolio in Q3 2022.
  • Raymond James & Associates opened 200 new positions and closed 283 in Q3 2022.
  • Raymond James & Associates's portfolio value fell 3.3% quarter-over-quarter to $98.8B.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.